Towards Healthcare
Pharmaceutical Grade Melatonin Market to Reach USD 1044.3 Mn by 2034

Pharmaceutical Grade Melatonin Market Redefines Wellness

Based on market forecasts, the global pharmaceutical grade melatonin market, projected at USD 479.9 million in 2024, is expected to reach USD 1044.3 million by 2034, growing at a CAGR of 8.56% over the forecast period. The rising prevalence of sleep disorders and the burgeoning tourism sector drive the global market. The presence of key players and favorable regulatory policies contributes to North America’s dominance.

Content

  • Last Updated: 27 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The pharmaceutical grade melatonin market is valued at USD 521 million in 2025 and is on track to reach USD 1044.3 million by 2034, witnessing a steady CAGR of 8.56% during the forecast span.

North America is leading the pharmaceutical grade melatonin market share by 50% due to the availability of state-of-the-art research and development facilities and the increasing number of clinical trials.

Some key players include Natrol LLC, Vitaquest International LLC, and Pharmavite LLC.

Goji berries, tart cherries, certain fruits, oily fish, nuts, and oats are some of the natural foods that contain the highest amounts of melatonin.

National Institute of Health, GOV.UK, American Academy of Sleep Medicine, Statistique Canada, Alzheimer Association
Any Questions